Trial Profile
Evaluation of Pantoprazole (PPI) on Glucose - Insulin homeostasis in patients with Type-2 Diabetes Mellitus: A Randomized Double Blind Placebo Controlled (Proof of Concept) Study.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PANDIT
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 12 Jun 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met according to results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.